Comunicati.net - Comunicati pubblicati - Varie Comunicati.net - Comunicati pubblicati - Varie Sun, 22 Sep 2019 10:15:06 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://comunicati.net/comunicati/aziende/varie/1 Gli esperti considerano l'osteoporosi una vera e propria epidemia silenziosa che, secondo quanto emerso dal nuovo sondaggio pubblicato in data odierna, è trascurata e non adeguatamente affrontata Sat, 21 Sep 2019 22:52:46 +0200 http://comunicati.net/comunicati/aziende/varie/598569.html http://comunicati.net/comunicati/aziende/varie/598569.html Pr NewsWire Aziende Pr NewsWire Aziende
 

View in Browser

 

News From UCB

Transmitted by PR Newswire for Journalists on September 21, 2019 10:51 PM CEST
 

Gli esperti considerano l'osteoporosi una vera e propria epidemia silenziosa che, secondo quanto emerso dal nuovo sondaggio pubblicato in data odierna, è trascurata e non adeguatamente affrontata

 
 

- Si stima che l'osteoporosi colpisca 200 milioni di persone in tutto il mondo1 e che provochi una frattura ogni 3 secondi2, eppure una recente indagine rivela che gli specialisti in Europa ritengono che non sia adeguatamente riconosciuta3

- Gli specialisti intervistati (82%) ritengono che l'osteoporosi sia un'epidemia silenziosa, eppure solo il 24% di loro crede che il loro sistema sanitario sia adeguatamente preparato a sostenere i pazienti affetti da osteoporosi3

 - Secondo la metà (53%) degli specialisti, i loro pazienti ritengono che l'osteoporosi o le fratture da fragilità abbiano un effetto solo nel breve termine3, nonostante la chiara evidenza dell'impatto a lungo termine sulla qualità della vita e sulla loro indipendenza4,5

BRUXELLES, 21 settembre 2019 /PRNewswire/ -- Una recente indagine europea, pubblicata in data odierna da UCB, rivela che gli specialisti ritengono che l'osteoporosi e le fratture da fragilità siano trascurate e non siano considerate una priorità dai rispettivi sistemi sanitari e che sia quindi necessario intervenire.3 L'indagine, condotta ad agosto 2019, ha richiesto a 401 specialisti di 11 Paesi europei di descrivere la loro esperienza nella gestione dell'osteoporosi e delle fratture da fragilità.3

Il 66% dei partecipanti all'indagine condivideva l'opinione che l'osteoporosi sia una condizione trascurata e solo il 10% degli specialisti ha affermato che l'osteoporosi e le fratture da fragilità sono attualmente considerate altamente prioritarie dalle autorità sanitarie locali.3 La maggioranza (90%) ritiene che la condizione debba essere considerata una priorità sanitaria pubblica e il 91% ha affermato che una gestione più efficace potrebbe migliorare gli outcome e ridurre i costi.3 Attualmente, nelle donne di oltre 45 anni di età, l'osteoporosi è responsabile di più giorni di ricovero ospedaliero rispetto a numerose altre malattie, compresi il diabete e il tumore al seno.6 Nel 2010, il costo delle fratture da fragilità nell'Unione Europea è stato di €37 miliardi7 e, sulla base dei cambiamenti demografici in atto, è destinato a raddoppiare entro il 2050.1

"Questi risultati confermano ciò che molti di noi già sapevano. Ogni anno che passa, a sempre più pazienti viene potenzialmente negata una gestione efficace della patologia e questo li espone a fratture in grado di cambiare la loro vita. Abbiamo bisogno di gruppi di pazienti e di consulenti che possano sostenere gli specialisti nazionali per implementare approcci efficaci in modo da rendere il tema una priorità per le istituzioni politiche, i medici di base e i pazienti", ha commentato il Dott. Kassim Javaid, Consulente in reumatologia presso l'Università di Oxford. "Benché il fine ultimo sia prevenire la prima frattura, servizi integrati di gestione del paziente post-frattura come il Fracture Liaison Service (FLS) hanno iniziato a colmare il divario nell'ambito delle cure sanitarie ed è adesso necessario espanderli a livello internazionale. Una volta attivati questi sistemi, i modelli FLS possono evolversi per identificare i gruppi di pazienti ad alto rischio e prevenire la prima frattura, che resta il nostro obiettivo primario."

L'indagine suggerisce inoltre che i pazienti non siano bene informati sull'osteoporosi e sul relativo impatto. Solo un terzo (33%) degli specialisti ritiene che i loro pazienti comprendano l'impatto a lungo termine dell'osteoporosi e più della metà (53%) afferma che i loro pazienti ritengono che vi sia un rischio basso o nullo di fratture da fragilità successive alla prima,3 nonostante l'evidenza mostri che dopo avere subito la prima frattura si corre un rischio cinque volte superiore di subire un'altra frattura entro un'anno.8 La situazione è ulteriormente aggravata tra le persone che hanno una frattura dell'anca: il 40% non è più in grado di camminare autonomamente9 e fino a un quarto delle persone che hanno una frattura dell'anca muore durante l'anno successivo alla frattura.10,11

Inoltre, l'indagine ha evidenziato che le problematiche di gestione dell'osteoporosi possono anche risiedere a livello di cure primarie. La maggioranza (84%) degli specialisti intervistati ritiene che siano necessarie una maggiore consapevolezza e una maggiore comprensione dell'osteoporosi da parte dei medici di base e solo il 32% ha affermato che i medici di base inviano tempestivamente a uno specialista le diagnosi sospette di osteoporosi.3

Essendo l'osteoporosi la patologia ossea più comune a livello globale, che causa oltre 8,9 milioni di fratture da fragilità ogni anno in tutto il mondo,12 è necessario fare di più per istruire e sostenere i medici di base e I pazienti sull'importanza di una gestione efficace e un tempestivo consulto specialistico.

"I pazienti affetti da osteoporosi possono dover affrontare una grave perdita dell'indipendenza e una qualità della vita ridotta, soprattutto dopo avere subito una frattura da fragilità. I risultati di questa indagine evidenziano che, secondo gli specialisti, non si fa abbastanza per garantire la priorità necessaria a livello di sistema sanitario", ha affermato Pascale Richetta, Head of Bone ed Executive Vice President di UCB. "Dobbiamo contribuire a prevenire il diffondersi di questa epidemia silenziosa educando maggiormente le istituzioni politiche, i medici e i pazienti sull'impatto a lungo termine dell'osteoporosi, in modo da poter gestire efficacemente questa condizione e da ridurre il rischio di successive fratture."

Informazioni sull'indagine

UCB ha condotto un'indagine presso operatori sanitari specializzati in disturbi del metabolismo osseo. L'indagine è stato condotto in agosto-settembre 2019 come parte di un'iniziativa mirata a indagare gli atteggiamenti e la priorità percepita dell'osteoporosi e delle fratture da fragilità in undici dei principali Paesi industrializzati: Germania, Spagna, Francia, Regno Unito, Grecia, Irlanda, Italia, Lituania, Paesi Bassi, Polonia e Romania. 401 professionisti sanitari sono stati intervistati online in merito all'osteoporosi e alle fratture da fragilità.

Informazioni su UCB

UCB, Bruxelles, Belgio (www.ucb.com) è un'azienda biofarmaceutica globale dedicata alla scoperta e allo sviluppo di farmaci e soluzioni innovative per trasformare la vita delle persone che convivono con malattie gravi del Sistema immunitario o del sistema nervoso centrale. Con 7.500 dipendenti in circa 40 Paesi, l'azienda ha generato utili per €4,6 miliardi nel 2018. UCB è quotata alla borsa Euronext di Bruxelles (simbolo: UCB). Seguici su Twitter: @UCB_news

Bibliografia

  1. Reginster JY, Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006 Feb;38 (2 Suppl 1):S4-9
  2. Johnell O and Kanis JA (2006). Osteoporos Int 17:1726
  3. SERMO. Osteoporosis study for UCB 2019.
  4. Bentler SE, et al. Am J Epidemiol. 2009;170:1290-1299.
  5. Cosman F, et al. Osteoporos Int. 2014;25:2359-2381.
  6. Kanis JA, Delmas P, Burckhardt P, et al. (1997). Osteoporos Int 7:390.
  7. Hernlund E, Svedbom A, Ivergard M, Compston J, et. al. 10.1007/s11657-013-0136-1. 2013, 8(1-2):136
  8. van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ. Ann Rheum Dis 2009;68:99�“102.
  9. Magaziner J, Simonsick EM, Kashner TM, et al. J Gerontol 1990;45:M101.
  10. Cooper C, Atkinson EJ, Jacobsen SJ, et al. Am J Epidemiol 1993;137:1001.
  11. Leibson CL, Tosteson AN, Gabriel SE, et al. J Am Geriatr Soc 2002;50:1644.
  12. Ström O, Borgström F, Kanis JA, et al. Arch Osteoporos. 2011;6:59-155. doi: 10.1007/s11657-011-0060-1.

SOURCE UCB

CONTACT: Per maggiori informazioni: Scott Fleming, Bone Communications Lead, UCB, Tel. +44 7702 777378, scott.fleming@ucb.com. France Nivelle, Global Communications, UCB, Tel. +32.2.559.9178, france.nivelle@ucb.com, Laurent Schots, Media Relations, UCB, Tel. +32.2.559.92.64, laurent.schots@ucb.com
 
View in Browser
 
                                                           
]]>
Global Small Caliber Ammunition Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 Sat, 21 Sep 2019 11:11:46 +0200 http://comunicati.net/comunicati/aziende/varie/598509.html http://comunicati.net/comunicati/aziende/varie/598509.html Bharat Book Bureau Bharat Book Bureau Bharat Book Bureau Provides the Trending Market Research Report on "Global Small Caliber Ammunition Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024" under Weapons category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.

Small caliber ammunition is .50 caliber and below. Conventional small caliber ammunition in production and deployment consists of 5.56 mm, 7.62 mm, 9 mm, 10- and 12-gauge, .22 caliber, .30 caliber, .38 caliber, .45 caliber, .300 WinMag and .50 caliber.

Scope of the Report:

• Currently, there are several producing companies in the world small caliber ammunition industry. The main market players are Orbital Atk, Vista Outdoors, Olin Corporation, Ruag Group, FN Herstal and Nammo. The production of small caliber ammunition will increase to 23024 Million Rounds in 2018 from 21186 Million Rounds in 2013 with average growth rate of 1.68%.

• In consumption market, North America, Asia-Pacific and Europe are the mainly consumption regions due to the bigger demand of downstream applications. In 2017, these regions occupied 88.01% of the global consumption volume in total.

• Small caliber ammunition has different caliber size, which include 5.56mm, 7.62mm, 9 mm, 12.7 mm Caliber, etc. And each type has application industries relatively. With increasing demand of military and hunting & sport activities, the downstream application industries will need more small caliber ammunitions. So, small caliber ammunition has a huge market potential in the future.

• The worldwide market for Small Caliber Ammunition is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 7210 million US$ in 2024, from 6390 million US$ in 2019.

• This report focuses on the Small Caliber Ammunition in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request a free sample copy of Small Caliber Ammunition Market @
https://www.bharatbook.com/marketreports/sample/reports/1370517

Market Segment by Manufacturers, this report covers

• Orbital Atk

• Vista Outdoors

• Olin Corporation

• Ruag Group

• FN Herstal

• Nammo

• Nexter

• BAE Systems

• Poongsan Defense

• IMI

• Remington

• Hornady

• Rio Ammunition

• General Dynamics

• CBC Ammo Group

• NORINCO

• CSGC

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)

• Europe (Germany, France, UK, Russia and Italy)

• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

• South America (Brazil, Argentina, Colombia etc.)

• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• 5.56mm Caliber

• 7.62mm Caliber

• 9 mm Caliber

• 12.7 mm Caliber

Market Segment by Applications, can be divided into

• Military

• Law Enforcement

• Civilian

The content of the study subjects, includes a total of 15 chapters:

• Chapter 1, to describe Small Caliber Ammunition product scope, market overview, market opportunities, market driving force and market risks.

• Chapter 2, to profile the top manufacturers of Small Caliber Ammunition, with price, sales, revenue and global market share of Small Caliber Ammunition in 2017 and 2018.

• Chapter 3, the Small Caliber Ammunition competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

• Chapter 4, the Small Caliber Ammunition breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

• Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

• Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

• Chapter 12, Small Caliber Ammunition market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

• Chapter 13, 14 and 15, to describe Small Caliber Ammunition sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Browse our full report with Table of Content :
https://www.bharatbook.com/marketreports/global-small-caliber-ammunition-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024/1370517

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com

Follow us on : TwitterFacebookLinkedIn

]]>
Giornata Mondiale della Pace 2019: Diventa un sostenitore dei diritti umani! Fri, 20 Sep 2019 23:49:52 +0200 http://comunicati.net/comunicati/aziende/varie/598434.html http://comunicati.net/comunicati/aziende/varie/598434.html volontariato volontariato I diritti umani iniziano dal fatto che ognuno di noi insista che siano conosciuti e usati da tutti, ovunque.

Sabato 21 Settembre i volontari “La via della felicità Cervia - Amici di L. Ron Hubbard” saranno a Ravenna per le vie del centro per fare una distribuzione di opuscoli sui Diritti Umani.

Ogni anno il 21 settembre si celebra la Giornata internazionale della pace in tutto il mondo. L'Assemblea Generale lo ha dichiarato come un giorno dedicato al rafforzamento degli ideali di pace, sia all'interno che tra tutte le nazioni e tutti i popoli.

Le persone che si preoccupano degli altri e che lavorano per creare diritti umani per tutti hanno fatto grandi progressi nel persuadere i governi ad adottare e rispettare i diritti umani in tutto il mondo.e si celebra la Giornata internazionale della pace in tutto il mondo. L'Assemblea Generale lo ha dichiarato come un giorno dedicato al rafforzamento degli ideali di pace, sia all'interno che tra tutte le nazioni e tutti i popoli.

Ma le continue violenze ed abusi in tutto il mondo dimostrano che è necessaria un’altra cosa essenziale: i diritti umani devono essere conosciuti ed applicati, compresi. E osservati da tutti.

Ci sono molti modi in cui puoi aiutare a far si che i diritti umani elencati nella Dichiarazione Universale dei Diritti Umani siano conosciuti ed usati.

Visto il tema della giornata mondiale 2019 “"Azione per il clima e per la pace", farli conoscere e sensibilizzare sul tema è una responsabilità e risponde al Diritto Umano #29, che si allinea perfettamente al Diritto Umano #3 Diritto alla vita: visto che il cambiamento climatico causa minacce chiare alla pace e alla sicurezza internazionali.

Catastrofi naturali e conflitti spingono le popolazioni a spostarsi in altre terre, dove si sviluppano difficoltà di ogni genere che possono portare ad ulteriori conflitti o possono mettere a repentaglio un clima di pace.

Ma cosa si può fare per migliorare l’ambiente? Da piccoli gesti, come raccogliere un mozzicone di sigaretta gettato a terra, o piantare un albero, a strategie mondiali sulle emissioni che portino ad un miglioramento ambientale, si parla di fare qualcosa, uniti, per un mondo di Pace.

Informati, visita il sito www.unitiperidirittiumani.it

]]>
Outsourced Drug Discovery Market Advancements to Watch Out For 2026 Fri, 20 Sep 2019 15:09:40 +0200 http://comunicati.net/comunicati/aziende/varie/598385.html http://comunicati.net/comunicati/aziende/varie/598385.html Coherent Market Insights Coherent Market Insights Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organizations (CMO). Contract research organization provides support to the pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.

Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2847

Market Dynamics

New strategies adopted by key players related to outsourcing drug discovery is expected to drive the growth of the global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.

Furthermore, the extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2017, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to preclinical drug development for the treatment of respiratory diseases and rare diseases.

The increasing number of drug discovery companies is expected to drive the growth of the global outsourced drug discovery market

The increasing number of new drug discovery companies is expected to drive the global outsourced drug discovery market growth. For instance, in November 2018, Schrodinger, LLC collaborated with Wuxi AppTec and launched a new drug discovery company, Faxian Therapeutics (Headquarter– New York, U.S.). Faxian Therapeutics will utilize the Schrodinger, LLC’s computational platform and WuXi’s drug design and synthesis services to improve health care needs.

Moreover, rising drug discovery services are expected to propel the growth of the global outsourced drug discovery market. For instance, in April 2019, Eurofins Discovery Services, a contract research organization, launched a new drug discovery service DiscoveryOne. The new approach is helpful for drug discovery research activities and preclinical developments. Hence, the launching of services related to drug discovery is expected to support the global outsourced drug discovery market growth.

Global Outsourced Drug Discovery Market - Competitive Landscape

Key players operating in the global outsourced drug discovery market are Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd., Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.

Detailed Segmentation:

  • Global Outsourced Drug Discovery  Market, By Drug Type:
    • Small Molecule Drugs
    • Large Molecule Drugs
  • Global Outsourced Drug Discovery Market, By Services:
    • Preclinical Development
    • Target Validation and Functional Informatics
    • Target Identification and Screening
    • Lead Identification and Candidate Optimization
    • Others
  • Global Outsourced Drug Discovery Market, By Application
    • Oncology
    • Ophthalmology
    • Hematology
    • Immunomodulation
    • Anti-Infective Drugs
    • Dermatology
    • Pulmonology
    • Cardiology
    • Others
  • Global Outsourced Drug Discovery Market, By End User
    • Pharmaceutical and Biotechnological Companies
    • Contract Research Organization
    • Contract Manufacturing Organization

Global Outsourced Drug Discovery Market- Regional Analysis

North America outsourced drug discovery market is expected to account for the largest market share, owing to business expansion in this region. For instance, in January 2019, Lambda Therapeutic Research (Headquarter-India) acquired Novum Pharmaceutical Research Services, a U.S. CRO. With this acquisition, Lambda Therapeutic Research entered into the U.S. market.

Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/2847

Moreover, Europe is also projected to witness significant growth in the global outsourced drug discovery market, owing to increased merger and acquisition activities by key players in the region. For instance, in February 2019, Optimapharm, a clinical research organization (CRO) in Europe acquired Denothex, a CRO, for strengthening its presence in the European market particularly in France, Spain, Switzerland, and Italy. Denothex conducts all clinical trials in oncology across Europe and Israel.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

]]>
Asia-Pacific Drugs For Hormonal Replacement Therapy Market Size, Trends and Forecast to 2022 Fri, 20 Sep 2019 14:15:11 +0200 http://comunicati.net/comunicati/aziende/varie/598348.html http://comunicati.net/comunicati/aziende/varie/598348.html TBRC TBRC A report from TheBusinessResearchCompany shows that the "Global Drugs For Hormonal Replacement Therapy Market 2019" is expected to grow to $7.09 billion at a CAGR of 9.0% through 2022.

The Business Research Company’s Drugs For Hormonal Replacement Therapy Global Market Report 2019 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Explore Complete Report “Drugs For Hormonal Replacement Therapy Global Market 2019” at https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Ratios of market size and growth to related markets, GDP proportions, and expenditure per capita for the market is detailed in the report. Data and analysis throughout the report is sourced using end notes.

The global drugs for hormonal replacement therapy market was valued at about $5.02 billion in 2018 and is expected to grow to $7.09 billion at a CAGR of 9.0% through 2022.

Major Key competitive players in the global Drugs For Hormonal Replacement Therapy market report include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company.

The drugs for hormonal replacement therapy market is a segment of the pharmaceuticals market. The report will answer questions such as where the largest and fastest growing market is, how the market relates to the overall economy, demography and other similar markets, and what forces will shape the market going forward.

Request to get the sample of this report https://www.thebusinessresearchcompany.com/sample.aspx?id=2575&type=smp

Drugs for hormonal replacement therapy market consists of sales of drugs for hormonal replacement therapy and related services. The drugs for hormonal replacement therapy are used to treat patients with growth hormone deficiency caused due to conditions such as dwarfism or menopause (a condition which describes changes a woman goes through when her menstruating cycle stops). The drugs for hormonal replacement therapy help to replace low level hormones from the body, maintain growth hormone deficiency and prevent women from vaginal dryness, mood swings, weakening of bones and others.

List of Tables from the Report:

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 4: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 5: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

.

.

Table 66: Novartis AG Financial Performance

Table 67: Bayer AG Financial Performance

Table 68: Pfizer Inc. Financial Performance

Table 69:  Novo Nordisk A/S Financial Performance

Table 70:  Eli Lilly and Company Financial Performance

For latest press releases visit https://www.thebusinessresearchcompany.com/press-release.aspx

About Us:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

]]>
Ill Effects of Self-medication Practices to Ramp up the Adoption of Earwax Removal Aids: Fact.MR Fri, 20 Sep 2019 13:53:15 +0200 http://comunicati.net/comunicati/aziende/varie/598333.html http://comunicati.net/comunicati/aziende/varie/598333.html Fact.MR Fact.MR  

Earwax removal aids are the medical tools used to remove earwax caused due to excessive formation of cerumen. The earwax removal aid includes micro-suction device, earwax removal irrigation kits, earwax removal drops, earwax removal loops, earwax removal syringes, and portable ear cleaning devices.

According to the Fact.MR report, retail sales, especially in developing regions, is projected to show remarkable growth, due to easy availability of over-the-counter earwax removal aids.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4100

The healthcare industry is consistently witnessing an uplift in the number of ENT surgeries every year, globally, due to rising prevalence of ENT-related disorder. Around 3-5% of ear disorders is because of earwax impaction. It is also due to the adoption of improper treatment method with self-analysis by the individual with earwax impaction. The traditional practices increase the disease morbidity, and at a certain point, it requires urgent medical attention. This is the major factor responsible for the growth of the earwax removal aid market.

Adult Age Group Remains the Target Population for Manufacturers

Use of earwax removal kits among adults are likely to grow in the coming years, as carelessness, and negligence of cerumen impaction symptoms along with high adoption of self-diagnosis treatment continue to increase the risk of infection, affecting the ear-health adversely. This has led to high usage of earwax removal aid among this age group.


Increasing Awareness in Social Media to Upsurge Treatment-seeking Population

Social media plays a vital role in raising awareness regarding ear-health among large number of population. With the significant development of digital platforms, a majority of the population have a YouTube channel or an Instagram account, thereby making it easy to raise awareness among wide range of population. Many people have uploaded their videos of going through an earwax removal process on YouTube and Instagram, which has millions of viewers. This trend of the social media platform has upsurge the awareness, and in turn, increased the treatment-seeking population.

Product Sales through Online Platforms to Boost the Market Growth

Sale of products through online platforms such as Amazon, Flipkart, eBay, and others are gaining momentum among manufacturers, and are expected to drive the demand for earwax removal aid devices. Also, costs of the earwax removal aids are very economical and many generic products are available in the earwax removal aids market. Moreover, the average selling price of the earwax removal aids is expected to decrease in the forecast period.

Preview Analysis – https://www.factmr.com/report/4100/earwax-removal-aid-market

Usage of Earwax Removal Aid in Home Care Settings

The earwax removal aid is largely adopted in the home care settings, because it is easily available in drug stores, retail pharmacies, and online sales channels. Also, one can purchase the earwax removal aid over-the-counter. Due to self-diagnosis trend, many people prefer to use earwax removal aid at their home.

East Asia to Hold a Large Revenue Share in the Earwax Removal Aid Market

East Asia is expected to be the most prominent market in terms of market share in the earwax removal aid market, owing to large number of patients with cerumen impaction and availability of economical earwax removal aid product range. On the account of improved healthcare infrastructure and rising healthcare expenditure per capita, manufacturers are viewing developing countries in the Asia Pacific region from target market perspective.

According to the study, growth opportunities for the earwax removal aid market players are picking up the pace in the East and South Asia regions, owing to increasing patient pool suffering from earwax impaction. The availability of economical earwax removal aids coupled with increasing initiatives to raise awareness in schools and colleges regarding ear health provides an opportunity for the growth of earwax removal aid market.

FacT.MR business intelligence also underlines groundbreaking insights into the competitive scenario of the earwax removal aid market, along with highlights of manufacturers’ differential strategies. The earwax removal aid market is majorly covered by the local players. The key players’ operating in the earwax removal aid market will continue to focus on delivery of their products through various distribution channels and to spread the awareness among the population regarding ear hygiene. The adoption of these products is mainly due to brand recognition, cost-effectiveness, and availability, which strengthen the company’s product portfolio.

Read PR at- https://www.factmr.com/media-release/1074/global-earwax-removal-aid-market

 

]]>
Peak Flow Meters to Ride on ‘Portability’ Quotient, Gains Remain Driven by Introduction of Smart and Efficient Variants: Fact.MR Fri, 20 Sep 2019 13:49:58 +0200 http://comunicati.net/comunicati/aziende/varie/598330.html http://comunicati.net/comunicati/aziende/varie/598330.html Fact.MR Fact.MR Peak flow meters are the portable devices used to measure the activity in lungs and to evaluate how well the lungs are able to expel the air. It is a lung monitoring device and is used to measure peak expiratory flow rate and forced expiratory volume.

According to the Fact.MR report, the patients, especially in developing regions, will continue to significantly prefer peak flow meters, due to the low prices of mechanical peak flow meters.

Increasing prevalence of asthma and chronic obstructive pulmonary disease, rising awareness among the people regarding various respiratory diseases, and relatively high rate of smoking in recent years are expected to propel the growth of peak flow meters market.

Apart from the driving factors, there can be few factors such as use of spirometers, poor availability of the devices in some regions and low awareness among the people, can hinder the overall growth of peak flow meters market.

Smart Pocket Peak Flow Meters – A Key Growth Influencer

The introduction of smart peak flow meters, can be proved as an opportunity for the growth of the peak flow meter market. Smart peak flow meters are the pocket devices that can be connected to the smart phones. Hence, increasing adoption of smart peak flow devices, are expected to increase the growth of the peak flow meters market.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4099

Digital Peak Flow Meter to Capture Significant Share

There are two types of products in the peak flow meter market – mechanical peak flow meters and digital peak flow meters. Digital peak flow meters is the leading segment in the peak flow meters market and holds a substantial revenue share in the peak flow meters market.


High Application Potential in Measurement of Peak Expiratory Flow Rate

Peak expiratory flow rate measurement is the application, which hold a large share in the overall peak flow meters market, as it is measured by both the digital peak flow meter and the mechanical peak flow meter as well.

Home care settings remain a prominent end user for peak flow meters, accounting for a significant revenue share in the overall market. Moreover, owing to portable nature of peak flow meters, many people prefer them to use them, at their homes.

North America Lead Gains, Asia Pacific Presents Lucrative Opportunities

North America is expected to hold a significant market share in the peak flow meter market owing to the technological advancement, especially in the field of healthcare industry.

According to the study, growth opportunities for the peak flow meter market players are picking pace in Asia Pacific region, owing to increasing population and increasing number of people suffering from asthma and COPD. The increasing government initiatives and favorable reimbursement for the diagnosis of respiratory diseases, provides an opportunity for the growth of peak flow meters market.

Request Research Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4099

Fact.MR business intelligence also underlines groundbreaking insights into the competitive scenario of peak flow meters market along with highlights of the manufacturers’ differential strategies. Key players in the peak flow meters market will continue to focus on the introduction of new advertisements and new healthcare awareness programs, to spread the awareness among the people regarding various commonly occurring respiratory diseases. The key manufacturers in peak flow meters market are focusing to strengthen their product portfolio. The companies are also focusing on geographical expansion.

Read PR at- https://www.factmr.com/media-release/1077/global-peak-flow-meter-market 

]]>
The Escalating Role of Expanded Polystyrene in Construction Sector has Heightened its Overall Growth Reveals Fact.MR Fri, 20 Sep 2019 13:47:18 +0200 http://comunicati.net/comunicati/aziende/varie/598328.html http://comunicati.net/comunicati/aziende/varie/598328.html Fact.MR Fact.MR According to a recently published Fact.MR report, global value sales of Expanded Polystyrene reached over US$ 15 Bn in 2019, and are poised to record a significant growth through 2019. The report opines that East Asia will hold its dominance in the Expanded Polystyrene market, underlined by the persistent demand from end-use industries in the region. The presence of key manufacturers in the area includes BASF SE, Total S.A., Synthos S.A., Wuxi Xingda New Foam Plastics Materials Co., Ltd, Versalis S.P.A., and others are complementing a value sales of the Expanded Polystyrene in the region. Recycling deadlocks will coerce market players towards extending provisions on reuse.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4080

The rising usage in several different applications across end use industries will boost the demand for Expanded Polystyrene to provide a sustainable growth rate to the global Expanded Polystyrene market. Sheathing in residential and commercial construction is the most basic and widely used application for EPS insulation. In 2018, East Asia accounted for over 40% value sales of Expanded Polystyrene market. The several schemes and government projects for urbanization in India such as “housing for all” has given a boost to the construction industry in this region. Similarly, the road and marine network from China to Italy, ‘One Belt One Road Initiative’ by China will enhance the construction activities and propel the demand of Expanded Polystyrene during the forecast period. Among other regions, Europe is expected to gain a significant market share in terms of both value, as well as volume, owing to the presence of well-developed industries. South Asia and Oceania are likely to witness strong growth as compared to other developed and developing regions.

Ceaseless Growth of the Construction Sector Driving the Need for Expanded Polystyrene

Rapid infrastructural and construction activities, fueled by the economic boom in emerging economies, is foretold to drive the expanded polystyrene market in the construction sector. Polymers have become increasingly important as an engineering material and one of the essential building blocks in the construction of engines, vehicles, household articles, and buildings. The construction industry is typically quite cautious about changing tried-and-tested methods and requires new materials to have a proven track record. The versatility of EPS allows it to be used for a huge variety of different purposes includes Snow sports helmet, Infant car seats, Air conditioning units, Seating for sports and others. Nevertheless, the benefits of expanded polystyrene are often too great to ignore and they are making a big impact in a growing number of areas.

Request Research Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4080

High Insulating Properties and Moisture Resistance have made Expanded Polystyrene a Popular Choice

The effectiveness of packaging revolves mainly around surviving the drops. Foam materials continue to pass the drop tests successfully and ensure that the goods being wrapped incur the least amount of shock, regardless of their fragility. The above features are anticipated in the usage of Expanded Polystyrene in several applications across the packaging industry. Key players in the global Expanded Polystyrene market continue to dutifully test their solutions across a range of drop heights and fragility indexes. Flexibility of Expanded Polystyrene materials has been exceptional in dissipating the impact of the fall. Meanwhile, Expanded Polystyrene materials wrapped around rugged objects with sharp corners can demonstrate low levels of impact responsiveness, and can lower the static stress immediately. Dynamic cushioning properties and anti-corrosive properties of Expanded Polystyrene are further boosting their use in production of protective packaging solutions. End-users are astutely adopting foam protective packaging to avoid additional costs arising from faulty shipping processes leading to escalated growth of global Expanded Polystyrene market in the forecast period.

The Fact.MR report offers forecast of the Expanded Polystyrene market for the period 2019-2027. According to the report, the Expanded Polystyrene market is projected to record over 4% CAGR through 2027. The Packaging sector continues to generate lucrative value opportunities for players engaged in manufacturing of Expanded Polystyrene for packaging.

Read PR at- https://www.factmr.com/media-release/1071/global-expanded-polystyrene-market]]>
Tubal Obstruction Devices Market to register a healthy CAGR for the forecast period 2018 2028 Fri, 20 Sep 2019 12:40:49 +0200 http://comunicati.net/comunicati/aziende/varie/598295.html http://comunicati.net/comunicati/aziende/varie/598295.html Fact.MR Fact.MR The growing awareness for controlling the population in order to curb the increasing challenges pertaining to the growing population and the extensive impact on the economy is giving a boost the various birth control alternatives such as tubal obstruction devices, especially in developing countries which include China, India and the United States.  The tubal obstruction devices are largely used in the procedures owing to their precise and advanced design and the growing need for conception. The Tubal Obstruction Devices Market is expected to witness a growth in the coming years owing to the increasing application and developments.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=872

The key market participants which include Idea Connection Ltd. are seen involving greater commercialization of the tubal obstruction devices and seeking industrial partners for the same. The company is seen taking continuous efforts for providing improved tubal obstruction devices for greater and improved delivery for patients. Moreover, the need for conception and effective birth control are fueling the tubal obstruction devices market, which is then giving a boost to the research and developments of the tubal obstruction devices.

Tubal obstruction devices are micro-insert devices used for prevention of pregnancy and maturation of egg in ovaries. Tubal obstruction devices are used in birth control and working two principles namely tissue ingrowth and mechanical obstruction. Tubal obstruction devices is a minimally invasive method for birth control. Mostly these devices are made up of polyethylene, ceramic, nylon, and silicone. The first FDA approved tubal occlusion device is Essure permanent birth control system. In recent times, it has become popular because of its minimally invasive nature with the high degree of effectiveness. This device consists of two coils namely: inner coil and the outer coil. Inner coil is made up of polyethylene terephthalate fibers and stainless steel and outer is made up of nitinol. It is used for permanent birth control by inducing benign tissue ingrowth. The success rate of this device is 83% to 94.1% and it offers advantages like avoidance of incisions, general anesthesia, and general narcotics.  

To know more about the Tubal Obstruction Devices Market Visit the link- https://www.factmr.com/report/872/tubal-obstruction-devices-market  

During past decade, tubal obstruction devices have become increasingly popular due to the fact that they can achieve either permanent or reversible conception. Increasing demand for permanent birth control procedure boosts the growth of tubal obstruction devices market. Rising population in emerging countries like India & China etc. pose a significant threat to economies of the country. In order to control the population of the countries, governments have taken many initiatives to raise awareness among the general population. Along with government initiatives, increasing knowledge among the general population regarding growing concerns about overpopulation has a significant effect on the market. Tubal obstruction device offers more benefits over conventional techniques because it’s minimally invasive with fewer side effects. The rapid advancement of technologies enabled tubal obstruction devices to comply more with patient personal requirements. Improved patient compliance also boosted the growth of the market. All these factors fueled the growth of the tubal obstruction devices market.

The lack of substantial data regarding large patient pool is expected to limit the growth of tubal obstruction devices market.

Global Tubal Obstruction Devices Market has witnessed a robust growth due to increasing demand for devices. They are minimally invasive with minimum side effects and it is more advantageous over conventional surgery. Tubal Obstruction Devices Market has a presence of a few players which have a huge market share in global market operating at the country level. There are huge opportunities for the untapped markets across the world due to potential benefits of Tubal Obstruction Devices Market. The key players in the Tubal Obstruction Devices Market are mainly focused on R&D to accelerate the development due to a limited number of manufacturers. The future of Tubal Obstruction Devices Market anticipated with double CAGR during forecasting period.

Tubal Obstruction Devices Market: Region-wise Overview

Global Tubal Obstruction Devices Market is segmented into the following regions - North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and the Middle East & Africa. North America is dominant in the global tubal obstruction devices market mainly due to the increasing penetration. In North America, the USA is dominating the market due to high adoption among end users. Economic conditions in the APAC region are set to drive the tubal obstruction devices market to new heights. Europe and APAC tubal obstruction devices markets are the fastest growing regions due to increasing awareness. Growth in the Middle East & African region is considerably less when compared to the other regions. However, North America would maintain its position in the tubal obstruction devices market, though, we are anticipating developed economies such as Australia to have the highest growth rate in Tubal Obstruction Devices Market.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=872

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Telemetry Pouch Market Forecasts and Growth 2018 2028 Fri, 20 Sep 2019 12:32:27 +0200 http://comunicati.net/comunicati/aziende/varie/598289.html http://comunicati.net/comunicati/aziende/varie/598289.html Fact.MR Fact.MR A telemetry pouch is a wearable pouch used to hold a telemetry unit (cardiac monitor). It can be worn over or under the clothing so that it stays secure, and most are adjustable to fit different body sizes. It has soft straps for comfort around the neck; some have a strap for the torso, and most are adjustable to fit individual body sizes. Telemetry Pouch Market are used to secure telemetry transmitters to patients, help prevent artifacts (static) in the information relay from the transmitter to the CMS, and help prevent transmitters from falling off or being subjected to food or drink spills. This pouch is used to carry telemetry equipment when a patient suffers a heart attack or undergoes cardiac surgery, and must be regularly monitored by telemetry equipment.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=949

The pouch can be attached to the patient with a soft foam strap or a name badge clip. There is a flap closure system that works with a hook and loop closure. These pouches come with a 2.25″ x 2.25″ patient label. They offer the same patient comfort and easy color identification, as well as include a clear front made from polyethylene/nylon for viewing the content. Though the pouch is resistant to fluid contamination, it is still the most economical pouch due to its material. Frequently, this pouch is put inside a patient’s gown pocket and clipped to the gown.

The growing adoption of telemetry pouches by patients such as coronary patients is the major factor which is driving the telemetry pouch market. In addition to this, its ease of use and necessity are the other factors which are propelling the telemetry pouch market.

The cost effectiveness and disposability of these types of pouches are other factors which are pushing the market towards growth. The characteristics of telemetry pouches, such as ideal for patient monitoring, lightweight due to the nonwoven material, durability, designed as per single-patient use, long straps, and front flap with a snap button that holds the monitor securely in place, are some of the other product-related factors which are pushing the market towards growth.

Tentatively, the global telemetry pouch market has been segmented on the basis of product type, distribution channel, and geography.

To know more about the Telemetry Pouch Market Visit the link- https://www.factmr.com/report/949/telemetry-pouch-market

The global market for telemetry pouches is expected to witness moderate growth over the forecast period. The presence of major players and expanding reach of products in developing as well as under developing countries are factors which are boosting the market. The increased patient pool requiring continuous telemetry monitoring needing telemetry pouches is a key factor which is playing a major role in propelling the global telemetry pouch market. The hospital pharmacies distribution channel is expected to contribute the highest share as it is the most accessible channel.

Geographically, the global telemetry pouch market is classified into regions, viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the leader in the global telemetry pouch market, owing to high incidences and prevalence of patients requiring telemetry monitoring. The market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players, and expanded reach in countries. Europe is expected to take the second-largest share in the global telemetry pouch market throughout the forecast period.

The global market for diverticular disease therapeutics is highly fragmented. Some of the major players identified in the global telemetry pouch market are Graham Medical, Medline Industries, Inc., Covidien, Koninklijke Philips N.V., RAM Surgical, EME Company, and DeRoyal Industries, Inc, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=949

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Subcutaneous Injection Ports Market Forecast and Segments 2018 and 2026 Fri, 20 Sep 2019 12:25:07 +0200 http://comunicati.net/comunicati/aziende/varie/598286.html http://comunicati.net/comunicati/aziende/varie/598286.html Fact.MR Fact.MR Subcutaneous injection ports have witnessed significant momentum, owing to their key benefits such as reducing the number of needle sticks required in blood samples, nutrition, fluids, and medication. Subcutaneous injection ports have also witnessed increased acceptance among healthcare professionals as they ebb the irritation in blood vessels caused by some medicines.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=876

With long-term risk being relatively lower in use of subcutaneous injection ports as compared to other venous catheters, along with lower requirement for maintenance and care has been driving demand for Subcutaneous Injection Ports Market. Healthcare professionals have been focusing on the evaluation of an entirely implanted system that comprises subcutaneous injection port attached to silicone elastomer-based central venous catheter.

Subcutaneous injection ports have also been deemed successful, devoid of flushing between uses, irreversible catheter occlusion, and system-related infections. The subcutaneous injection ports are likely to replace central venous catheters, based on both maintenance requirement between uses and patient acceptance. However, risks involved with surgery and anesthesia during insertion that include blood clots, nerve injury, and puncture of blood vessel continue to remain a key challenge to be addressed in use of subcutaneous injection ports.

Key medical device manufacturers are focusing on the development of discreet subcutaneous injection ports, which feature an inserter for patients using syringes or pens for administering multiple injections daily. Such discreet subcutaneous injection ports are likely to be suitable for both adult as well as pediatric use, thereby gaining market acceptance and driving growth of the subcutaneous injection ports market.

Subcutaneous injection is considered a standard method for the delivery of medication into a patient’s body. To facilitate subcutaneous injection, subcutaneous injection ports are used. Subcutaneous injection ports are sterile medication delivery device. Subcutaneous injection ports consists of a silicone injection membrane on a hard base. Through subcutaneous injection port physician prescribed medications can be directly injected into the subcutaneous tissue using a standard needle and syringe, an injection pen, or other manual injection device. Subcutaneous injection port is a device that cannot be used with an injection pump. Furthermore, subcutaneous injection ports are also used for multiple subcutaneous injections for a period of up to 72 hours. Subcutaneous injection port avoids the repeated needle punctures of the skin. This device is widely used for patients who require prolonged central venous access. A subcutaneous injection port is generally a disposable device usually inserted into the skin for a period of up to 5 days. Insulin is injected through a syringe into subcutaneous injection port. Medicines are directly injected through the resealable septum at the top of the device. The needle of the syringe is placed above the surface of the skin whereas the medication is delivered through the soft cannula. A subcutaneous injection port consists of a build in inserter, which give users a virtually painless application.  A subcutaneous injection port is usually used with an intrathecal or epidural catheter. Subcutaneous injection ports have low infection rate, but require suitable expertise for their insertion.

To know more about the Subcutaneous Injection Ports Market Visit the link- https://www.factmr.com/report/876/subcutaneous-injection-ports-market

The global subcutaneous injection ports market is expected to witness a significant growth over the forecast period due to rising prevalence of cancer and diabetes across the globe. Increasing investment of manufacturers in the development of subcutaneous injection port is further driving the growth of the global subcutaneous injection ports market. Furthermore, over the past decade, more patient-friendly devices have enhanced the demand for subcutaneous injection ports. However, lack of focus on health expenditure, declining reimbursements and others factors are the hindrance of the global subcutaneous injection ports market.

On the basis of geography, the global subcutaneous injection ports market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and the Middle East & Africa. North America will continue to dominate the global subcutaneous injection ports market due to the availability of advanced technologies. Europe is expected to hold the second large market share in the global subcutaneous injection ports market. Asia Pacific is also one of the fast-growing regions in the global subcutaneous injection ports market due to high incidence of diabetes in low-income countries. Moreover, the Middle East and Africa and Latin America are expected to show slow growth in the global subcutaneous injection ports market due to delayed introduction of the product in these regions.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=876

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Sinus Implants Market To Make Great Impact In Near Future by 2018-2028 Fri, 20 Sep 2019 12:16:47 +0200 http://comunicati.net/comunicati/aziende/varie/598284.html http://comunicati.net/comunicati/aziende/varie/598284.html Fact.MR Fact.MR Growth of sinus implants market can be attributed towards increasing demand for minimally invasive techniques and promising reimbursement scenario for the sinus procedures, especially in the developed regions. ENT clinics are expected to drive revenue growth of sinus implants market on account of increasing preference of patients towards treatments in ENT clinics, cost-effectiveness and faster recovery time. North America is anticipated to hold lion’s share in sinus implants market prominently owing to growing geriatric population and increasing adoption of innovative and new technologies amongst otolaryngologists and ENT surgeons. Asia-Pacific is expected to prove lucrative for Sinus Implants Market owing to improving standard of living, rising medical tourism, large population base and growing prevalence of the sinus-related diseases.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=950

Key players and manufacturers are taking immense initiatives by making heavy investments in Intersect ENT Inc. for expanding awareness regarding SINUVA sinus implants. SINUVA sinus implants is a new technique for treating nasal polyp disorder in adult patients. Extensive research and development has been carried out for launching this sinus implants and is clinically proven for reducing polyps as well as symptoms of the nasal congestion. However, recurring nasal polyposis has been posing great challenges for ENT physicians, thereby hampering the growth of sinus implants. This challenge has been significantly curbed with adoption of SINUVA sinus implants.

The sinuses are air-filled cavities presents around the area of nose and eyes. Sinus allows natural ventilation and drainage. However, in chronic sinusitis cases, sinus linings gets inflamed due to chronic infections and nasal obstruction, that lead to blocking of natural drainage passageways. Major symptoms associated with chronic sinusitis are nasal congestion, facial pain or pressure, discolored nasal discharge, difficulty in breathing, headache, fatigue depression among others. More than 31 million people are affected with chronic sinusitis each year in the US. Steroid medication is the first line of treatment for sinusitis. However, most of the patients treated with medication have poor response rate which results in more number of patients opting for surgical approach. The increased number of patients undergoing surgery named Functional Endoscopic Sinus Surgery (FESS) are performed to widen sinus passage. The FESS surgery have some complications such as scarring, new polyp growth to the patient which are eliminated through implantable sinus stents/spacers which are used following FESS procedure. These implants maintain patency of the sinuses and also help in controlled release of medication such as corticosteroid.

Distinct attributes of sinus implants such as direct delivery of steroid medication to sinus cavity lining minimize or completely erase the need for additional oral corticosteroid medications. The effective delivery of corticosteroid reduced the post-surgery side effects such as discomfort, congestion, and scarring. The sinus implants also improve the success rate of FESS surgery and reduce the probabilities of additional surgery. The significant benefits of sinus implant in conjugation with FESS surgery is expected to fuel the market growth. In addition, the growing awareness among otolaryngologists about the use of sinus implant post FESS surgery through various certifications and courses spur the adoption rate of sinus implant globally. However, potential side effects such as premature displacement of implant, swallowing implant associated with sinus implant would hinder the market growth.

Browse Full Report with TOC: https://www.factmr.com/report/950/sinus-implants-market

Growing number of FESS based procedures pave the path for sinus implants market. The enhanced success rate of FESS procedures followed by sinus implants would be the key growth factor for sinus implant market. Favorable reimbursement guides (Category I CPT codes in 2011) for sinus implants are attracting large medical device manufacturers to enter into the market. Companies such as Medtronic have capability to build drug releasing stents. However, small companies are likely to gain competencies by developing novel product line in the market. However, risk of product liability claims to sinus implant imposes a threat to market growth due associated side effects, manufacturing defects, misuse or abuse of sinus implants products. Such product liability claims lead to costs of litigation, product recall from the market which eventually affects the revenue generation for the manufacturers.

Geographically, global sinus implants market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America & Europe region would witness double digits growth owing to shift in trend of hospital based FESS procedure to physician’s office. Another reason behind the lucrative growth opportunity of sinus implant market is increasing prevalence of chronic sinusitis which is anticipated to promote the growth of FESS procedure in the North America & European region. Medical tourism in ASEAN countries would be the key success factor for the growth of sinus implant market. The lower cost of FESS surgery over US/EU countries makes Asia region a favorable destination for FESS surgery.

Some of the players identified in global Sinus Implants market include Intersect ENT, Inc. In Dec 2017, the company had received FDA approval for its SINUVA Sinus Implant indicated for nasal polyps treatment, in patients (above 18 years) who have undergone ethmoid sinus surgery. The approval was supported by the clinical outcome of 400 patients including RESOLVE II pivotal study.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=950

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

]]>
Silicone Gel-Filled Breast Implant Market Shares, Strategies and Forecast Worldwide 2018 2026 Fri, 20 Sep 2019 12:07:36 +0200 http://comunicati.net/comunicati/aziende/varie/598282.html http://comunicati.net/comunicati/aziende/varie/598282.html Fact.MR Fact.MR Silicone gel-filled breast implants have been approved by the US Food & Drug Administration for breast augmentation among women aged over 22 years. Breast reconstruction is also a lucrative area where silicone gel-filled breast implants seek significant demand, along with their use in the revision surgeries that rectify or improve results of the original surgery. Silicone Gel-Filled Breast Implant Market is expected to witness bullish prospects as these are not lifetime devices and are associated with periodic replacements.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=875

However, frequent complications experience by patients with silicone gel-filled breast implants, including infection, pain, scarring, asymmetry, wrinkling, and implant rupture, along with capsular contracture and reoperation continue to ebb growth of the Silicone Gel-Filled Breast Implant Market. Much attention has been focused on silicone gel-filled breast implants in recent years, with concerns regarding silicone leak into bodies of these implant recipients.

MRI prevails as an effective silent rupture detection method in patients with silicone gel-filled breast implants. Palpability of MRI in the silicone gel-filled breast implant market is complemented by the FDA’s recommendation for MRI screening post-three years of receiving the implant. Although no direct association has been observed between silicone gel-filled breast implants and tissue diseases, reproductive problems, and breast cancer, more research is required for definitively ruling out concerns of these complications.

The FDA required manufacturers of silicone gel-filled breast implants to update their product labelling to include safety information. Update on the Safety of Silicone Gel-Filled Breast Implants by the FDA includes preliminary results of studies needed by manufacturers during approval and review of available scientific data.

Silicone gel-filled breast implants consist of an outer shell made of silicone and filled with silicone gel. The silicone gel is a bit more like natural breast tissue. Silicone gel-filled breast implants are available in different sizes with smooth or textured shells. Generally, silicone gel-filled breast implants are approved for breast augmentation and breast reconstruction surgeries. FDA-approved silicone gel-filled breast implant is for breast augmentation in women aged 22 or older and for breast reconstruction in women of any age.

To know more about the Silicone Gel-Filled Breast Implant Market Visit the link- https://www.factmr.com/report/875/silicone-gel-filled-breast-implant-market

Moreover, the implants are also used in revision surgeries which improve or correct the result of an original surgery. Usually, breast implants are not lifetime devices. Adverse and frequent complications experienced by breast implant patients include reoperation, capsular contracture, and implant removal. Some of the other complications include wrinkling, implant rupture, asymmetry, pain, scarring, and infection. Breast implantation surgery increases the probability of being diagnosed with anaplastic large cell lymphoma (ALCL). MRI is considered to be an effective method for detecting silent rupture of silicone gel-filled breast implants.

According to FDA, there are five silicone gel-filled breast implants been approved, namely Allergan Natrelle (approved in November 2006), Allergan Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (approved in February 2013), Mentor MemoryGel (approved in November 2006), Mentor MemoryShape (approved in June 2013) and Sientra’s Silicone Gel Breast Implants (approved in March 2012).

According to a journal published in the U.S., it was estimated that around 93,083 breast reconstruction procedures and 296,203 breast augmentation procedures were performed in 2010. In 2015, according to the estimates of the American Society for Aesthetic Plastic Surgery, approximately 47.9% of breast implant procedures were undertaken by women belonging to the age group of 19–34 years in the U.S.

The growth of the global silicone gel-filled breast implant market is driven by increasing prevalence and incidence of breast cancer in the global population. For instance, according to the research conducted in 2017, it is estimated that 1 in every 8 (nearly 12%) women will develop invasive breast cancer over the course of the lifetime in the U.S. alone. Furthermore, population drifting towards aesthetic appearance and increasing disposable income are also driving the growth of the global silicone gel-filled breast implant market. However, the high cost related to breast implantation surgeries and lack of skilled personnel are the major factors hampering the growth of the global silicone gel-filled breast implant market. Most of the cases of breast implants cause health problems as women with implants need additional surgeries to replace or remove their implant. This hampers the growth of the silicone gel-filled breast implant market. In addition, it is also estimated that one in four women who get breast implants will require additional surgery. The cost of removing or replacing breast implants can be higher than the cost of getting implants in the first place.

On the basis of geography, the global silicone gel-filled breast implant market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and the Middle East & Africa. The North America silicone gel-filled breast implant market is expected to hold the large share in the global market, followed by Europe, due to the increasing prevalence and incidence of breast cancer. Moreover, increasing number of cancer surgeries coupled with the presence of sophisticated healthcare infrastructure is also boosting the growth of the silicone gel-filled breast implant market. The silicone gel-filled breast implant market in the Asia Pacific region is expected to grow at a higher rate due to the presence of large population base, and favorable reimbursement scenario. However, the market for silicone gel-filled breast implant in regions such as Latin America, and the Middle East and Africa are estimated to show a stagnant growth over the forecast period. Latin America is expected to gain future opportunities due to the increasing medical tourism in countries such as Brazil, Mexico, and Argentina.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=875

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Pneumatic Equipment Market Trends, Regulations And Competitive Landscape Outlook to 2026 Fri, 20 Sep 2019 12:01:04 +0200 http://comunicati.net/comunicati/aziende/varie/598281.html http://comunicati.net/comunicati/aziende/varie/598281.html Fact.MR Fact.MR Pneumatic equipment market has been gaining significant traction because of its utilization in nearly every field and broad application in the end-user industries. The use of pressurized gas for motion is called pneumatics, and upon compressing atmospheric air, there are equipment that can efficiently maintain a sustainable supply. The equipment that carry out such mechanisms to obtain movement are pneumatic equipment. Various pneumatic equipment are included in the Pneumatic Equipment Market such as pneumatic valves, actuators, fittings, etc. These pneumatic equipment are an integral part of electronics, metalworking, chemicals, life sciences, material handling and many more industries. Pneumatic equipment market has also been observed to expand its horizons in food and beverage as well as healthcare industries.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=1901

Pneumatic equipment like pneumatic actuators are widely used in healthcare applications like surgeries and MRI. Pneumatic tube systems are also being used extensively to transport drugs, prescriptions, patient notes, etc. in the hospitals, thereby driving the pneumatic equipment market.

Growing Automation in Industries to Drive the Pneumatic Equipment Market

Construction and mining industries are benefitting highly through pneumatic equipment such as energy efficient pneumatic actuators that save nearly 2% compressed air. With applications in almost every sector, pneumatic equipment market is expected to showcase robust growth in the near future. There have also been several innovations in the technology for pneumatic sealing, further aiding the pneumatic equipment market sales.

Increasing globalization and urbanization has induced significant changes in consumer lifestyle across the globe. The expensive products like virtual reality stimulators also deploy pneumatic equipment such as valves, actuators and power drives. Pneumatic equipment like power engines and motors are booming in the global market because of their broad use in the automation industry. The manufacturing sector in the developing economies such as China and India have witnessed a rapid development accounting for an appreciable growth rate. The pneumatic equipment market has, therefore, a positive effect because of its penetration in the modern world manufacturing industry. However, the rise of electrical solutions is emerging as a challenge for the pneumatic equipment market due to their capability to fulfill the same requirements as in pneumatic equipment.

To know more about the Pneumatic Equipment Market, Visit the link- https://www.factmr.com/report/1901/pneumatic-equipment-market

Pneumatic Equipment to Penetrate in Broad Range of End-user Industries

Pneumatic equipment market is segmented on the basis of product type, end use and region. The product types include pneumatic valves, actuators, Filters, Regulators and Lubricators (FRL), fittings and other pneumatic equipment. Among all the pneumatic equipment product types, the actuators have been reported to account for leading share in sales. On the basis of end-users, the pneumatic equipment market is classified into, automotive, food processing and packaging, chemicals, plastics, and oil, semiconductors and electronics, material handling and assembly, metalworking, paper and printing, wood and ceramic, healthcare, life sciences, aerospace and defense and others. The penetration of pneumatic equipment in chemicals and metal working industry is very high as compared to other industries. Material handling industry also deploys a wide range of pneumatic equipment among the other end-use industries. Pneumatic equipment is also likely to gain traction in the healthcare and food processing industry owing to the increasing use of automation in these industries.

Developing Economies to Continue Dominance

In terms of regions, the pneumatic equipment market has been broadly divided into seven regions, namely, North America, South America, Europe, CIS and Russia, Japan, APEJ and MEA. Despite the concentration of players in North America, pneumatic equipment manufacturers are primarily concentrated in Asian countries, mostly China. Focus on energy efficiency and increased penetration of automation are the key factors driving the market for pneumatic equipment in the APEJ region. The Chinese and Indian manufacturing sector is exhibiting robust growth in the region. The manufacturers have inclined towards automation combined with the use of pneumatic equipment for increased efficiency and productivity. The inexpensive labor and the new labor laws have also supported the manufacturing industry, providing a large market for pneumatic equipment in the region. Apart from APEJ, North America and Europe are also anticipated to depict growth in the upcoming year in the pneumatic equipment market. Some of the key market players in pneumatic equipment market are AVENTICS, Festo, Parker Hannifin, Ross Controls, SMC, Butech, Camozzi, Clippard, Emerson ASCO, Janatics, Mindman, Siemens and other prominent players.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1901

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Perianal Infection Treatment Market Set for Rapid Growth And Trend, by 2028 Fri, 20 Sep 2019 11:50:52 +0200 http://comunicati.net/comunicati/aziende/varie/598277.html http://comunicati.net/comunicati/aziende/varie/598277.html Fact.MR Fact.MR Increasing patient pool owing to higher incidence rates of anal fistula and the recurrence rate of the treated cases is significantly driving Perianal Infection Treatment Market Growth In addition, growing incidences of anal fistula stimulating co-morbidities has led to more complicated anal fistula cases, thereby driving the demand for perianal infection treatment. Rising demand for effective and safe perianal infection treatment with assurance of no recurrence and lesser side-effects have been creating growth opportunities for manufacturers. This in turn will lead to development of advanced and new devices and drugs benefitting perianal infection treatment market.           

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=952

North America is likely to pose lucrative revenue growth opportunities for perianal infection treatment market on account of burgeoning healthcare expenditure by consumers and early adoption of the innovative and new technologies. Asia-Pacific perianal infection treatment market is likely to grow at an impressive pace on account of trending medical tourism, improving healthcare infrastructure and growing awareness regarding perianal infection treatment. However, dearth of awareness regarding perianal infection treatment coupled with inadequate medical infrastructure is expected to restrain the growth of Africa perianal infection treatment market. New product launches and technological advancements in perianal infection treatment will further stimulate the growth of perianal infection treatment market in the forthcoming years.

Perianal infection is most commonly caused by streptococcus and staphylococcus bacterial strains. Perianal infection, also called perianal streptococcal dermatitis, is a bright red, sharply demarcated rash that is caused by group A beta-hemolytic streptococci. Common symptoms of perianal infection include perianal rash, rectal pain & itching, blood or pus in stools, etc. Perianal infections most commonly occur in children between 6 months to 10 years of age. Poor hygiene is the major cause of perianal infections in children. Cases of perianal infection in adults are also reported, however, the incidence is rare. Initial observations show moist marinated erythema extended approximately 2-4 cm around the anus. Perianal infections may be accompanied by inflammation of the vulva & vagina in girls or end of the penis in boys. Most children diagnosed with perianal infection have positive cultures for group A beta-hemolytic streptococcal infections (GABHS). Common treatment options include topical antifungal agents such as topical amoxicillin, mupirocin, or penicillin. In severe cases, oral antibiotics are recommended. Oral antibiotic treatment shows dramatic improvement within 24 hours. Prolonged antibiotic treatment for 7-14 days is prescribed to increase the cure rate. Other antibiotics prescribed for the treatment of perianal infection include erythromycin, azithromycin, and clarithromycin, among others. However, in adults, perianal infections are not easily treated with oral antibiotics, and they require sufficiently long courses. According to a study conducted by The Association of Coloproctology of Great Britain and Ireland, only 42% adult patients with perianal infections were cured after the first course of antibiotics. In adults, additional anorectal or dermatological diseases may develop, which extend the course of treatment.

Growing incidences and recurrence of perianal infection is the major factor expected to drive the growth of the perianal infection treatment market over the forecast period. Approximately 39% of patients show recurrence of perianal infections. Recurrence may be caused due to poor compliance rates or incomplete treatment regimes. Incidences of additional anorectal diseases in adults such as haemorrhoids or damaged perianal skin is another factor driving the growth of the global perianal infection treatment market. However, lack of treatment adherence, low treatment seeking rates, misdiagnosis of a disease, etc., are the major factors deterring the growth of the global perianal infection treatment market.

To know more about the Perianal Infection Treatment Market Visit the link- https://www.factmr.com/report/952/perianal-infection-treatment-market

The global market for perianal infection treatment is expected to witness sluggish growth over the forecast period. Majority of the antibiotics have entered the generic market, and thus, there exists high competition among local and regional players. Among the two treatment type segments, oral antibiotics are most commonly prescribed, and the segment is expected to lead the global perianal infection treatment market over the forecast period 2018-2028. The retail pharmacies distribution channel is expected to contribute the highest growth share due to better accessibility to patients.

Geographically, the global perianal infection treatment market is classified into regions, viz. North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). Europe is expected to be the leader in the global perianal infection treatment market, owing to high incidence rates. The market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to improving treatment seeking rates. North America is expected to hold the second-largest share in the global perianal infection treatment market throughout the forecast period.

The global market for perianal infection treatment is highly fragmented, with numerous regional players operating in it. Some of the market players identified in the global perianal infection treatment market are Baxter International Inc., Hospira Inc. (Pfizer Inc.), Sandoz (Novartis AG), Arbor Pharmaceuticals LLC, Abbott, Eli Lilly & Co. Ltd., Allergen Plc., Teva Pharmaceutical Industries Ltd., Cardinal Health Inc., and Abbvie Inc. among others.

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=952

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Pediatric HIV Infection Treatment Market Value Share, Analysis and Segments 2018 2028 Fri, 20 Sep 2019 11:43:16 +0200 http://comunicati.net/comunicati/aziende/varie/598273.html http://comunicati.net/comunicati/aziende/varie/598273.html Fact.MR Fact.MR Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF. Evidence assures positive outcomes through early initiation of ART drugs for Pediatric HIV Infection Treatment Market. Focus of regulatory authorities is increasing on strategic targeting of more decentralized diagnostics along with clinical management for pediatric HIV infection treatment.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=874

Focus is also being placed on the integration of such approaches adolescent, child, and maternal services with communities and at care facilities, which in turn is expected to influence growth of the pediatric HIV infection treatment market. National action plans are being developed across countries worldwide for orphans and other vulnerable children, in a bid to enhance penetration of the pediatric HIV infection treatment.

This paradigm shift toward inclusive programs for aiding vulnerable children with pediatric HIV infection treatment is increasingly becoming a part of social welfare as well as assistance. As majority of the HIV-affected infants are found in the Sub-Saharan Africa, social protection programs are significantly scaling up in the region, which in turn is expected to positively affect growth of the pediatric HIV infection treatment market.

ART continues to remain the mainstay in the pediatric HIV infection treatment, as appropriate antiretroviral therapy as well as treatment of malignancies and infections has been deemed critical for pediatric HIV infection treatment. Pediatric HIV infection treatment market will witness the positive impacts of focus on early intervention as an effective measure to prevent damage to immune system as well as retard dissemination of infection.

During the past few years, the global burden of pediatric HIV infection is becoming a challenge for the healthcare industry. According to the World Health Organization, it is estimated that around 3.2 million people were living with HIV infection at the end of 2013. Majority of children acquire HIV infection from their HIV-infected mothers during pregnancy, breastfeeding or birth. Effective treatments can reduce the risk of mother-to-child HIV transmission. However, in most of the resource-limited countries where the burden of HIV is high, the treatment for pediatric HIV infection is still not widely available. Pediatric HIV infection causes immunologic deterioration, opportunistic infections, and cancers. Diagnosis of pediatric HIV infection includes viral antibodies and virologic nucleic acid amplification tests. Viral antibodies are given to children above 18 months whereas virologic nucleic acid amplification tests (such as PCR) are performed in children less than 18 months. Combination of antiretroviral drugs is given for the treatment of pediatric HIV infection. The general pathophysiology of pediatric HIV infection is similar to that in adults however, the clinical presentations, the method of infection and treatments often differ.  

To know more about the Pediatric HIV Infection Treatment Market Visit the link- https://www.factmr.com/report/874/pediatric-hiv-infection-treatment-market

Worldwide, each year, about 150,000 more children are infected (7 to 10% of all new infections) with HIV infection, and about 110,000 children die. Some of the risk factors related to the vertical transmission of HIV infection in children include high plasma viral RNA concentrations, seroconversion during pregnancy or breastfeeding, advanced maternal disease, and low maternal peripheral CD4+ T-cell counts. The most common signs of pediatric HIV infection not receiving ART include generalized lymphadenopathy, splenomegaly, oral candidiasis, hepatomegaly, CNS disease, failure to thrive, recurrent bacteremia, lymphoid interstitial pneumonitis, hepatitis, nephropathy, and others.

The market for pediatric HIV infection treatment is primarily driven by increasing prevalence of HIV infection in children. Active involvement of national and international government bodies to promote the research on HIV infection treatment drugs is responsible to drive the growth of the market during the forecast period. Moreover, increasing private-public partnerships for the research and development activities and increasing healthcare expenditure are also some of the factors driving the growth of the pediatric HIV infection treatment market. However, unavailability of treatment options in the underdeveloped countries can be the factor which can hamper the growth of global pediatric HIV infection treatment market. Moreover, the limited number of treatment options with a very high cost of branded drugs in various regions have impeded the growth of the global pediatric HIV infection treatment market.

On the basis of geography, global pediatric HIV infection treatment market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and Middle East & Africa. North America is expected to witness faster revenue growth in comparison with markets in other regions owing to higher infection rate amongst children and a large number of pediatric population suffering from HIV infection. Asia Pacific is also one of the fast growing regions in the global pediatric HIV infection treatment market due to high involvement of government-non-government bodies in promoting HIV infection treatment campaigns. Moreover, the Middle East and Africa and Latin America are expected to show less growth in the global pediatric HIV infection treatment market due to delayed introduction of treatment therapies in the regions.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=874

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

]]>
Non-invasive Coronary Imaging Market Volume Analysis, size, share and Key Trends 2018 2028 Fri, 20 Sep 2019 11:37:57 +0200 http://comunicati.net/comunicati/aziende/varie/598271.html http://comunicati.net/comunicati/aziende/varie/598271.html Fact.MR Fact.MR Coronary artery disease (CAD) is a cause of high mortality in the United States and claims more than 500,000 lives each year.  Non-invasive Coronary Imaging is used as a diagnostic and prognostic approach to assess the symptoms of patient suspected with coronary artery disease. Non-invasive Coronary Imaging is mainly performed on patients with myocardial infarction, coronary artery disease, or acute coronary syndromes with/without angina. Technologies with high efficacy in terms of disease diagnosis such as Radionuclide cardiac imaging; echocardiography; and, cardiac computed tomography and cardiac magnetic resonance imaging enhances the quality of Non-invasive Coronary Imaging Market. The integration of these technologies through various software solutions have enabled the physicians to remotely monitor the disease progression. The advancement in imaging sharing & analyzing through these platforms also decreases the associated cost of care. This has resulted in decreased disease burdens on countries with high prevalence of cardiac arrest/other CVS indications.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=931

The growing number of incidences of fatal cardiac injuries and potential risk of cardiovascular events have created a need for commercializing the non-invasive coronary imaging solutions. The reduction in price associated with infrastructure building and growing number of grants from government to establish advance imaging technologies are fueling the adoption of Non-invasive Coronary Imaging systems. The ability to provide precise and more accurate mapping of cardiac structure and function enabled the adoption of non-invasive coronary imaging systems during intraoperative cardiac sessions. The Non-invasive Coronary Imaging market also witness a shift in terms of technology adoption to high resolution CT/MRI imaging which has also reduced the turnaround time. The reduction in turnaround time led to increased number of tests conducted by each physician/surgeon. The increased number of tests conducted by end users also boost the ROI of capital intense Non-invasive Coronary Imaging technologies. However, the high cost of infrastructure associated with Non-invasive Coronary Imaging solutions is still a concern for resource poor countries. Moreover, the auxiliary cost of Non-invasive Coronary Imaging systems such as annual maintenance cost. Consumables cost is expected to reduce the adoption of Non-invasive Coronary Imaging. Limited awareness of end user for novel technologies is one of the major factors hindering the growth of Non-invasive Coronary Imaging market especially in Asia & Africa region.

To know more about the Non-invasive Coronary Imaging Market Visit the link- https://www.factmr.com/report/931/non-invasive-coronary-imaging-market

Non-invasive Coronary Imaging systems are successfully competing with conventional invasive methods such as catheter based or surgical interventions. The patient friendly attributes of Non-invasive Coronary Imaging is spurring the adoption of combinational imaging modalities cardiac computed tomography (MDCT) and magnetic resonance (MR) imaging in routine clinical practices especially for direct imaging coronary vasculature. Such as special features accelerated the growth of towards a gold standard approach for cardiac diagnostic and prognostic testing.

Non-invasive Coronary Imaging Market: Regional Outlook

Geographically, global Non-invasive Coronary Imaging market is classified into regions viz. North America, Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. Strong infrastructure spending and significant end use awareness makes North America as one of the growth region for Non-invasive Coronary Imaging market. In addition, the growing number of patients suffering from chronic CVS condition also fuelling the growth of North America Non-invasive Coronary Imaging market. European countries hold the second largest market share due to favorable reimbursement policies for cardiac indications. Markets in Asia and Africa regions are the most lucrative from the demand perspective due to large number of patient base seeking for more reliable and affordable Coronary Imaging solution.

Non-invasive Coronary Imaging Market: Key Players

Some of the players identified in global Non-invasive Coronary Imaging market include Toshiba Medical Systems, Hologic, Inc., Carestream Health, Inc. GE Healthcare, Siemens Healthcare, Philips Healthcare and Hitachi Medical Corporation. Strong entry barriers are in place for Non-invasive Coronary Imaging market which has increased the level of competition among the existing players. The companies operating the Non-invasive Coronary Imaging market are mainly competing on the basis of product differentiation strategy.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=931

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

 

]]>
Bambini non vaccinati e scuola: si attende la decisione del Tribunale di Trieste Fri, 20 Sep 2019 11:06:36 +0200 http://comunicati.net/comunicati/aziende/varie/598301.html http://comunicati.net/comunicati/aziende/varie/598301.html ComunicatiStampa.net ComunicatiStampa.net /**/
COMUNICATO STAMPA > Se non lo vedi correttamente Vedi sul Browser
 
 
 
ComunicatiStampa.net
 
 

Bambini non vaccinati e scuola: si attende la decisione del Tribunale di Trieste

Lettera del padre di un bambino escluso da scuola, in attesa della decisione del Tribunale di Trieste: il figlio è stato escluso da scuola 4 mesi fa, dando vita a un contenzioso giudiziario per cui si attende ora l’esito del ricorso

Udine, 20 settembre 2019 - Il sottoscritto Luca Scantamburlo e l' Avv. Michele Rodaro del Foro di Udine, che mi assiste nel contenzioso civile avverso il MIUR, contro la sospensione dalla frequentazione scolastica di mio figlio di anni quattro di età (avvenuta nel marzo 2019), dopo confronto approfondito - valutando pro e contro -abbiamo deciso di presentare reclamo all'Autorità giudiziaria del Tribunale Civile di Trieste, avverso l'ordinanza del Giudice dr. Francesco Saverio Moscato, la cui ordinanza a noi sfavorevole è stata emanata il 28 agosto 2019 (R.G. nr.1321/2019).

L’ordinanza del Giudice ha rigettato il ricorso cautelare richiesto d'urgenza da noi a fine marzo 2019.

Nello specifico il Giudice di Trieste - dopo aver ascoltato le parti in contradditorio a maggio 2019, ed aver acquisito delle note illustrative autorizzate entro il 17 giugno 2019, per approfondire la questione - ha ritenuto non sussistente alcuna posizione di "diritto soggettivo" da parte dei ricorrenti, i quali sarebbero titolari invece di un semplice "interesse legittimo".

Il deposito del reclamo ex art. 669-terdecies c.p.c. con la quale abbiamo chiesto al Collegio di Trieste un riesame della ordinanza, contro l'Istituto Comprensivo e contro il MIUR (resistenti) - difesi dall'Avv. Distrettuale dello Stato - è stato effettuato in data 13 settembre 2019.

Il pronunciamento dei Tribunale è atteso entro venti giorni dal deposito del reclamo.

Reclamo che verrà esaminato da un Collegio di tre giudici del Tribunale di Trieste (in composizione collegiale), i quali hanno facoltà - qualora lo ritenessero utile - di ascoltare le parti in un nuovo contradditorio, fissando eventualmente una ulteriore udienza.

Il Collegio, di cui non può far parte il giudice che ha emanato il provvedimento oggetto del reclamo, ha la facoltà di confermare, revocare o modificare il provvedimento del Giudice, e potrebbe emanare anche una ordinanza che a sostituzione della precedente decisione.

Con l'aiuto fornitomi da genitori e comitati di tutta Italia, sono riuscito a pagare l'onorario dell'Avvocato Michele Rodaro, mio difensore nominato. Già in occasione della intervista di RAI3 FVG a firma di Eva Ciuk  - il 09 maggio 2019 - in occasione della prima udienza fra le parti convocate dal Giudice Moscato (parte ricorrente l'Avv. Rodaro ed il sottoscritto, parte resistente l'Avv. Lorenzo Capaldo che difende il MIUR e per quanto possibile il Dirigente dell'Istituto comprensivo scolastico), il mio legale aveva affermato che la legge 119/2017 sia di fatto incostituzionale, chiedendo la reintegra immediata dell'alunno sospeso sine die. Nel reclamo si ribadisce la questione di legittimità costituzionale, argomentando che la applicazione di tale normativa sulla vaccinoprofilassi presenta "profili di incostituzionalità rilevanti", soprattutto in riferimento alla discriminazione di accesso scolastico relativa alla fascia di età 3-6 anni (scuola della infanzia).

Oltre al contenzioso civile, il sottoscritto si trova iscritto anche nel registro generale delle notizie di reato come "parte offesa". Anche in questa vicenda giudiziaria, il mio legale - diverso da quello nominato nel civile - ha depositato atto di reclamo avverso il decreto di archiviazione delle indagini disposto dal GIP di Roma,  nell'aprile 2019.

RECLAMO AVVERSO L'ARCHIVIAZIONE DELLE INDAGINI SUI MEDICINALI VACCINI: UDIENZA IL 24 OTTOBRE 2019 PRESSO IL TRIBUNALE PENALE

A fine luglio 2019 la Cancelleria del Tribunale di Roma - Sezione I Penale - su ordine del Giudice Claudia Nicchi ha trasmesso all'Avv. Alessandra Devetag dello Studio Volli del Foro di Trieste �“ attuale mio difensore nel penale �“ il decreto di fissazione udienza del reclamo depositato a fine maggio 2019 presso l'Autorità giudiziaria, ex art. 410 bis c.p.p. avverso il decreto di archiviazione delle indagini penali preliminari sulla sicurezza dei vaccini e la farmacovigilanza, durate circa due anni, ed archiviate nell'aprile 2019 dal Giudice GIP Claudio Carini di Roma, su richiesta del PM affidatario principale (la dr.ssa Maria Letizia Golfieri, R.G. nr. 50866/2017 c. ignoti).

Il reclamo è stato avanzato a causa della mancata notifica all'esponente (il sottoscritto) della richiesta di archiviazione del PM, notifica prevista ex art. 408 c.p.p., correttamente indicata nell'esposto che ha avviato le indagini dopo esame da parte del PM udinese della Procura di Udine, il quale a marzo 2017 aveva ravvisato ipotesi di reato penali contro ignoti, trasmettendo subito gli atti alla Procura della Repubblica di Roma, per competenza territoriale. Il fascicolo giudiziario ivi trasferito, in seguito si ingrossò ed accorpò altre denunce ed esposti presentati alle Autorità.
L'udienza per la camera di consiglio presso il Tribunale penale di Roma è fissata per il giorno 24 ottobre 2019, aula 3 ore 11.00. Le parti sono state avvisate ed hanno facoltà di presentare delle memorie.

In occasione della udienza, genitori e comitati da tutta Italia organizzeranno una manifestazione sit-in a mio sostegno, nei pressi di Piazzale Clodio, Tribunale penale di Roma. Le necessarie autorizzazioni sono già state richieste alla Questura di Roma.
Qualora il reclamo venga accolto, sarebbe nell'interesse anche delle altre parti offese, come il Codacons Roma. In caso di annullamento della archiviazione firmata dal GIP, sarebbe possibile formulare opposizione alla archiviazione voluta dal PM, e discutere davanti al Giudice la necessità di indagini supplettive.
Nell'esposto il sottoscritto pose l'accento sulla composizione dei vaccini ed eventuali polveri inquinanti estranee in essi presenti (sotto forma di particolato solido, micro e nanodimensionato) e riscontrate in diverse analisi condotte a campione da un laboratorio di analisi di eccellenza italiano, il quale ha indirettamente confermato ed approfondito la natura della contaminazione inorganica già emersa negli USA a metà anni '80 del secolo scorso, e divulgata da biologi e chimici americani (che pubblicarono i risultati su un periodico scientifico). All'epoca gli statunitensi non indagarono la natura dello stato della materia di tali inquinanti, ma si limitarono ad una analisi chimica qualitativa e quantitativa.

ROMA, 23 OTTOBRE 2019, CONVEGNO SU DIRITTO COSTITUZIONALE E BIOETICA GIURIDICA

La questione del diritto alla istruzione e della sua tutela, verrà affrontata in un convegno da me organizzato a Roma - ad ingresso libero, ma previa prenotazione - e che si svolgerà il 23 ottobre 2019 presso un grande albergo della capitale, di prima categoria.

Grazie al supporto di genitori a me vicini e da tempo molto attivi nell'ambito delle azioni civili - con addetti ai lavori accademici, esperti di diritto costituzionale, e di bioetica giuridica e filosofia del diritto: fra questi, il Prof. Avv. Daniela Granara, docente e ricercatore di diritto costituzionale presso la Università degli Studi di Genova, ed il prof. Alessandro Attilio Negroni, ricercatore di bioetica giuridica e filosofia del diritto, presso l'Istituto Tarello per la filosofia del diritto - Università degli Studi di Genova. Il prof. Granara terrà un intervento sui diritti inviolabili, e sul diritto alla salute ed il diritto alla istruzione nella Costituzione. Il prof. Negroni interverrà sul consenso informato ed il rispetto della persona umana.

Sarà presente come relatore anche l'Avv. Alessandra Devetag , avvocato cassazionista del Foro di Trieste, la quale parlerà di deontologia medica in rapporto ai diritti costituzionali, e dei rapporti fra scienza e politica.
Il convegno ed incontro culturale si terrà presso il centro congressi dell'Hotel Villa Maria Regina, "Sala Biblioteca",  Via della Camilluccia, 687, 00135 Roma (capienza sala, 300 posti a sedere).

Maggiori dettagli sull'evento sono reperibili all’indirizzo www.dirittinelcuore.net

Firmato

Luca Scantamburlo,

cittadino e genitore

19 settembre 2019


www.vaccinoconsapevole.blogspot.it 

 

Vedi online
 
 
 
 
 

Altri comunicati stampa recenti:

 
 
Rischi del 5G: a Gorlago incontro con sindaci e volontari della bergamasca

Rischi del 5G: a Gorlago incontro con sindaci e volontari della bergamasca

Milano, 20 settembre 2019 – Domenica 22 settembre alle ore 17 presso Qui Centro Polifunzionale Dinamico in Via del Fabbricone, 16, a Gorlago, in provincia di Bergamo, si terrà un incontro sul 5G organizzata dall’associazione “Amore con il mondo”. A partcipare non solo i volontari che intendono attivarsi sul territorio…

Leggi Tutto...
 
 
Cellulari e vacanze: in Spagna le maggiori rotture, gli uomini 25-35enni i più distratti

Cellulari e vacanze: in Spagna le maggiori rotture, gli uomini 25-35enni i più distratti

Sardegna, Lazio e Emilia Romagna le regioni italiane con le maggiori rotture di cellulari nell’estate 2019: il mare, i laghi e i locali notturni i luoghi più pericolosi per gli amati smartphone

Roma, 19 settembre 2019 – È l’estate la stagione pericolosa per i nostri smartphone. È durante le vacanze infatti che si verificano…

Leggi Tutto...
 
 
SkyMeeting Live rivoluziona la videoconferenza online

SkyMeeting Live rivoluziona la videoconferenza online

La Spezia, 19 settembre 2019 – Viene presentata oggi sul mercato SkyMeeting Live, la nuova rivoluzionaria piattaforma di videoconferenza per gestire riunioni online, corsi di formazione in aula virtuale, eventi e webinar a larga partecipazione e dirette live streaming su YouTube e Facebook.

Ad annunciare il lancio è Skymeeting SpA, PMI innovativa operante nel settore della…

Leggi Tutto...
 
 

Piano di Sorrento premia Gino Rivieccio per i 40 anni di carriera

Napoli, 18 settembre 2019 – L’attore Gino Rivieccio si aggiudica la sezione “Dino Verde” del Premio nazionale “Penisola Sorrentina” per i suoi 40 anni di carriera tra Mediaset, Rai e tanto teatro. Quarant’anni di spettacolo celebrati con un riconoscimento speciale del premio “Penisola Sorrentina”, la cui ventiquattresima edizione è in programma il prossimo 26 ottobre…

 

Oggi è la “Giornata Mondiale sulla Sicurezza dei Pazienti”: monumenti colorati di arancione per sensibilizzare l’opinione pubblica

Oggi è la “Giornata Mondiale sulla Sicurezza dei Pazienti”: gli errori in sanità provocano ogni anno 134 milioni di eventi avversi e 2,6 milioni di decessi. Un robot in arrivo, pronto per ridurre uno dei rischi maggiori: le cadute

San Giovanni Rotondo (FG), 17 settembre 2019 – L’Oms ha istituito per il 17…

Moda: un settembre ricco di novità per la fashion consultant comasca Monica Gabetta Tosetti

Milano, 17 settembre 2019 – È un settembre ricco di novità per la fashion consultant Monica Gabetta Tosetti, che passa dal red carpet del Festival del Cinema di Venezia ai nuovi servizi di consulenza in atelier, fino alla collaborazione con numerosi personaggi dello spettacolo come Clemente Russo

 
 
 
 
]]>
Coaching Experience Tour Fri, 20 Sep 2019 10:08:02 +0200 http://comunicati.net/comunicati/aziende/varie/598248.html http://comunicati.net/comunicati/aziende/varie/598248.html sole lancia sole lancia

Coaching Experience Tour

Il 27 settembre 2019 si terrà a Roma la tappa capitolina del Coaching Experience Tour, un corso di crescita e sviluppo personale. Attraverso gli strumenti del coaching si promuoverà la conoscenza di se stessi e la capacità di definire e perseguire obiettivi personali. Coaching Experience si rivolge a chi vuole avere un miglioramento personale e in qualsiasi ambito di vita, familiare, lavorativo, affettivo. Interessa pertanto imprenditori, manager, liberi professionisti ma anche insegnanti, genitori, allenatori, atleti e più in generale chiunque desideri ottenere risultati migliori rispetto al passato. Durante l’incontro si lavorerà anche per mettere a fuoco gli obiettivi reali, andando a comprendere cosa si desidera effettivamente e facendo chiarezza sulle motivazioni che rendono un determinato obiettivo appetibile e sensato. Il focus sarà sul trasmettere un aumento di consapevolezza rispetto a se stessi e ai propri mezzi, per mettere i partecipanti in grado di sfruttare le proprie risorse innate. L’evento è gratuito, per partecipare è sufficiente iscriversi sul sito di Prometeo Coaching, entrando nel menù del sito e cliccando sulla voce ‘corso di coaching gratuito’. In questo modo si accederà alla pagina dedicata, in cu sono presenti tutte le spiegazioni relative all’evento e la procedura per iscriversi. Il Tour avrà luogo oltre che a Roma, anche a Milano, Bari, Verona e Pescara. La giornata vedrà integrarsi contenuti teorici ed esercizi pratici, con distribuzione di materiale per lo svolgimento di questi ultimi. Chi parteciperà avrà l’opportunità di confrontarsi su temi importanti quali il modo di migliorare le proprie relazioni, ritrovare o rafforzare la motivazione e l’entusiasmo rispetto a se stesso e alla propria vita, imparare ad accedere e a gestire nuove importanti risorse utili a consolidare ciò che già ha e a realizzare nuovi progetti di vita. La mancanza di consapevolezza rispetto a ciò che si desidera realmente è spesso una causa del fenomeno del criceto dentro la ruota. Si gira invano perché non si ha chiaro dove si vuole andare e quale è la strada che conduce alla propria felicità. Riuscire a fare chiarezza su questi aspetti permette di ottimizzare il proprio tempo e raggiungere traguardi significativi. L’incontro sarà condotto dalla dottoressa Sole Lancia, direttore nazionale di O.P.E.R.A. Coaching, coach professionista, psicologa e psicoterapeuta, autrice del libro ‘chi cerca trova’, oggi disponibile in e-book sul giardino dei libri e su youcanprint. L’evento avrà luogo presso il Best Western Plus Hotel Universo, in via Principe Amedeo 5/B, dalle 15 alle 19. L'ingresso è gratuito sebbene sia obbligatoria l'iscrizione alla giornata in quanto l’evento è a numero chiuso e con distribuzione gratuita di materiale. E' possibile prenotarsi direttamente dal sito della Prometeo Coaching, ‘prometeocoaching.it’, cliccando sul menù alla voce ‘corso di coaching gratuito’  e nella finestra che si apre su ‘iscriviti gratis’. Conduttrice dell’evento è la dr.ssa Sole Lancia, coach professionista, psicologa, psicoterapeuta, direttore nazionale di O.P.E.R.A. coaching, autrice del libro ‘Chi cerca trova’ oggi disponibile in e-book e referente regionale ACoI per il Lazio. Il Coaching Experience Tour è un corso di crescita e sviluppo personale che utilizza gli strumenti del coaching per realizzare la versione migliore di ogni individuo. L’incontro avrà luogo dalle 15 alle 19 in via Principe Amedeo 5/B. L’incontro è rivolto a chi vuole migliorare le sue relazioni, ritrovare la giusta motivazione, utilizzare le sue risorse inespresse per raggiungere obiettivi e traguardi e migliorare come persona.

 

]]>
Coaching Experience Tour Fri, 20 Sep 2019 10:06:56 +0200 http://comunicati.net/comunicati/aziende/varie/598242.html http://comunicati.net/comunicati/aziende/varie/598242.html sole lancia sole lancia Coaching Experience Tour

Il 27 settembre 2019 si terrà a Roma la tappa capitolina del Coaching Experience Tour, un corso di crescita e sviluppo personale. Attraverso gli strumenti del coaching si promuoverà la conoscenza di se stessi e la capacità di definire e perseguire obiettivi personali. Coaching Experience si rivolge a chi vuole avere un miglioramento personale e in qualsiasi ambito di vita, familiare, lavorativo, affettivo. Interessa pertanto imprenditori, manager, liberi professionisti ma anche insegnanti, genitori, allenatori, atleti e più in generale chiunque desideri ottenere risultati migliori rispetto al passato. Durante l’incontro si lavorerà anche per mettere a fuoco gli obiettivi reali, andando a comprendere cosa si desidera effettivamente e facendo chiarezza sulle motivazioni che rendono un determinato obiettivo appetibile e sensato. Il focus sarà sul trasmettere un aumento di consapevolezza rispetto a se stessi e ai propri mezzi, per mettere i partecipanti in grado di sfruttare le proprie risorse innate. L’evento è gratuito, per partecipare è sufficiente iscriversi sul sito di Prometeo Coaching, entrando nel menù del sito e cliccando sulla voce ‘corso di coaching gratuito’. In questo modo si accederà alla pagina dedicata, in cu sono presenti tutte le spiegazioni relative all’evento e la procedura per iscriversi. Il Tour avrà luogo oltre che a Roma, anche a Milano, Bari, Verona e Pescara. La giornata vedrà integrarsi contenuti teorici ed esercizi pratici, con distribuzione di materiale per lo svolgimento di questi ultimi. Chi parteciperà avrà l’opportunità di confrontarsi su temi importanti quali il modo di migliorare le proprie relazioni, ritrovare o rafforzare la motivazione e l’entusiasmo rispetto a se stesso e alla propria vita, imparare ad accedere e a gestire nuove importanti risorse utili a consolidare ciò che già ha e a realizzare nuovi progetti di vita. La mancanza di consapevolezza rispetto a ciò che si desidera realmente è spesso una causa del fenomeno del criceto dentro la ruota. Si gira invano perché non si ha chiaro dove si vuole andare e quale è la strada che conduce alla propria felicità. Riuscire a fare chiarezza su questi aspetti permette di ottimizzare il proprio tempo e raggiungere traguardi significativi. L’incontro sarà condotto dalla dottoressa Sole Lancia, direttore nazionale di O.P.E.R.A. Coaching, coach professionista, psicologa e psicoterapeuta, autrice del libro ‘chi cerca trova’, oggi disponibile in e-book sul giardino dei libri e su youcanprint. L’evento avrà luogo presso il Best Western Plus Hotel Universo, in via Principe Amedeo 5/B, dalle 15 alle 19. L'ingresso è gratuito sebbene sia obbligatoria l'iscrizione alla giornata in quanto l’evento è a numero chiuso e con distribuzione gratuita di materiale. E' possibile prenotarsi direttamente dal sito della Prometeo Coaching, ‘prometeocoaching.it’, cliccando sul menù alla voce ‘corso di coaching gratuito’  e nella finestra che si apre su ‘iscriviti gratis’. Conduttrice dell’evento è la dr.ssa Sole Lancia, coach professionista, psicologa, psicoterapeuta, direttore nazionale di O.P.E.R.A. coaching, autrice del libro ‘Chi cerca trova’ oggi disponibile in e-book e referente regionale ACoI per il Lazio. Il Coaching Experience Tour è un corso di crescita e sviluppo personale che utilizza gli strumenti del coaching per realizzare la versione migliore di ogni individuo. L’incontro avrà luogo dalle 15 alle 19 in via Principe Amedeo 5/B. L’incontro è rivolto a chi vuole migliorare le sue relazioni, ritrovare la giusta motivazione, utilizzare le sue risorse inespresse per raggiungere obiettivi e traguardi e migliorare come persona.

 

]]>